Literature DB >> 30378439

Extending resectability of hilar cholangiocarcinomas: how can it be assessed and improved?

Marcello Donati1,2, Axel Stang3, Gregor A Stavrou4, Francesco Basile1, Karl J Oldhafer2,5.   

Abstract

Until the 1980's, Klatskin tumors were considered 'desperate cases' and most of them were not resected; almost no oncologic concept was available. After many improvements, today, extended hepatectomy, including caudate lobe resection and lymphoadenectomy, have become a standard of care for oncologicaly radical resection of Klatskin tumors. Portal vein en bloc resection, if necessary, is a diffused standard assuring R0-resection without any improvement of survival in most series. Arterial resection remains episodical and controversial in its oncologic impact. Arterial resection-reconstruction was demonstrated to be feasible with many different technical possibilities. Neoadjuvant chemotherapy, refinement of associating liver partition and portal vein ligation for staged hepatectomy and liver transplantations are some possible future resources for treatment of those aggressive tumors that could be able to expand the pool of treatable patients.

Entities:  

Keywords:  ALPPS; Klatskin tumors; extended hepatectomies; extended liver resections; hilar cholangiocarcinomas; neoadjuvant chemotherapy

Mesh:

Year:  2018        PMID: 30378439     DOI: 10.2217/fon-2018-0413

Source DB:  PubMed          Journal:  Future Oncol        ISSN: 1479-6694            Impact factor:   3.404


  3 in total

1.  FOXK1 plays an oncogenic role in the progression of hilar cholangiocarcinoma.

Authors:  Yujie Feng; Zhigang Bai; Jianning Song; Zhongtao Zhang
Journal:  Mol Med Rep       Date:  2020-12-10       Impact factor: 2.952

2.  Relationship between hepatic venous anatomy and hepatic venous blood loss during hepatectomy.

Authors:  Atsushi Nanashima; Yukinori Tanoue; Tatefumi Sakae; Isao Tsuneyoshi; Masahide Hiyoshi; Naoya Imamura; Takeomi Hamada; Koichi Yano; Takahiro Nishida; Mitsutoshi Ishii; Takeshi Nagayasu; Kunihide Nakamura
Journal:  Surg Today       Date:  2021-06-15       Impact factor: 2.549

3.  Prognostic Factors for Overall Survival in Advanced Intrahepatic Cholangiocarcinoma Treated with Yttrium-90 Radioembolization.

Authors:  Michael Köhler; Fabian Harders; Fabian Lohöfer; Philipp M Paprottka; Benedikt M Schaarschmidt; Jens Theysohn; Ken Herrmann; Walter Heindel; Hartmut H Schmidt; Andreas Pascher; Lars Stegger; Kambiz Rahbar; Moritz Wildgruber
Journal:  J Clin Med       Date:  2019-12-25       Impact factor: 4.241

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.